Expression of phosphorylated Stat5 predicts expression of cyclin D1 and correlates with poor prognosis of colonic adenocarcinoma

International Journal of Colorectal Disease

Volumn 26, Issue 1, 2011, Pages 29-35

  Mao, Yinling ^a   Li, Zhiwei ^a   Lou, Changjie ^a   Zhang, Yanqiao ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Cell cycle regulators (cyclin D1); Colon carcinoma; Immunohistochemistry; Prognosis; Signal transducer and activator of transcription 5 (Stat5)

Indexed keywords

CYCLIN D1; STAT5 PROTEIN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; COLON ADENOCARCINOMA; COLON RESECTION; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; COLONIC NEOPLASMS; CYCLIN D1; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHOSPHORYLATION; PROGNOSIS; STAT5 TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEINS;

EID: 78751591699     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-010-1090-7     Document Type: Article

References (30)

1. A Jemal R Siegel E Ward, et al. 2009 Cancer statistics, 2009 CA Cancer J Clin 59 225 249 10.3322/caac.20006 19474385
2. Y Toyoda T Nakayama Y Ito, et al. 2009 Trends in colorectal cancer incidence by subsite in Osaka, Japan Jpn J Clin Oncol 39 189 191 10.1093/jjco/hyn144 19164317
3. KW Jung YJ Won S Park, et al. 2009 Cancer statistics in Korea: incidence, mortality and survival in 2005 J Korean Med Sci 24 995 1003 10.3346/jkms.2009.24.6.995 19949651
4. L Bujanda C Sarasqueta E Hijona, et al. 2010 Colorectal cancer prognosis twenty years later World J Gastroenterol 16 862 867 10.3748/wjg.v16.i25.3103 20143465
5. W De Roock B Biesmans J De Schutter, et al. 2009 Clinical biomarkers in oncology: focus on colorectal cancer Mol Diagn Ther 13 103 114 19537845
6. R Buettner LB Mora R Jove 2002 Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention Clin Cancer Res 8 945 954 1:CAS:528:DC%2BD38XjsF2lsb4%3D 11948098
7. M Buitenhuis PJ Coffer L Koenderman 2004 Signal transducer and activator of transcription 5 (STAT5) Int J Biochem Cell Biol 36 2120 2124 1:CAS:528:DC%2BD2cXmslOit7Y%3D 10.1016/j.biocel.2003.11.008 15313458 (Pubitemid 39094434)
8. MT Nevalainen J Xie J Torhorst, et al. 2004 Signal transducer and activator of transcription-5 activation and breast cancer prognosis J Clin Oncol 22 2053 2060 1:CAS:528:DC%2BD2cXpsVWls7o%3D 10.1200/JCO.2004.11.046 15169792 (Pubitemid 41095137)
9. TK Lee K Man RT Poon, et al. 2006 Signal transducers and activators of transcription 5b activation enhances hepatocellular carcinoma aggressiveness through induction of epithelial-mesenchymal transition Cancer Res 66 9948 9956 1:CAS:528:DC%2BD28XhtVyiurrJ 10.1158/0008-5472.CAN-06-1092 17047057 (Pubitemid 44672047)
10. H Xiong WY Su QC Liang, et al. 2009 Inhibition of STAT5 induces G1 cell cycle arrest and reduces tumor cell invasion in human colorectal cancer cells Lab Invest 89 717 725 1:CAS:528:DC%2BD1MXmsVOrtbk%3D 10.1038/labinvest.2009.11 19290007
11. H Xiong ZF Chen QC Liang, et al. 2009 Inhibition of DNA methyltransferase induces G2 cell cycle arrest and apoptosis in human colorectal cancer cells via inhibition of JAK2/STAT3/STAT5 signalling J Cell Mol Med 13 3668 3679 10.1111/j.1582-4934.2009.00661.x 20196786
12. S Nam A Williams A Vultur, et al. 2007 Dasatinib (BMS-354825) inhibits Stat5 signaling associated with apoptosis in chronic myelogenous leukemia cells Mol Cancer Ther 6 1400 1405 1:CAS:528:DC%2BD2sXktFams7Y%3D 10.1158/1535-7163. MCT-06-0446 17431118 (Pubitemid 46712003)
13. CM Chien SH Yang KL Lin, et al. 2008 Novel indoloquinoline derivative, IQDMA, suppresses STAT5 phosphorylation and induces apoptosis in HL-60 cells Chem Biol Interact 176 40 47 1:CAS:528:DC%2BD1cXhtF2rtL7E 10.1016/j.cbi.2008.06. 008 18638462
14. QC Liang H Xiong ZW Zhao, et al. 2009 Inhibition of transcription factor STAT5b suppresses proliferation, induces G1 cell cycle arrest and reduces tumor cell invasion in human glioblastoma multiforme cells Cancer Lett 273 164 171 1:CAS:528:DC%2BD1cXhsVWnu7jP 10.1016/j.canlet.2008.08.011 18793823
15. JB O'Connell MA Maggard CY Ko 2004 Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging J Natl Cancer Inst 96 1420 1425 10.1093/jnci/djh275 15467030 (Pubitemid 39429665)
16. JR Jass LH Sobin H Watanabe 1990 The World Health Organization's histologic classification of gastrointestinal tumors. A commentary on the second edition Cancer 66 2162 2167 1:STN:280:DyaK3M%2FivFSksA%3D%3D 10.1002/1097-0142(19901115)66:10<2162::AID-CNCR2820661020>3.0.CO;2-N 2171747
17. T Kusaba T Nakayama K Yamazumi, et al. 2006 Activation of STAT3 is a marker of poor prognosis in human colorectal cancer Oncol Rep 15 1445 1451 1:CAS:528:DC%2BD28XlvVOisrc%3D 16685378
18. M Masuda M Suzui R Yasumatu, et al. 2002 Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma Cancer Res 62 3351 3355 1:CAS:528:DC%2BD38XkslWqsL8%3D 12067972
19. RS Lewis AC Ward 2008 Stat5 as a diagnostic marker for leukemia Expert Rev Mol Diagn 8 73 82 1:CAS:528:DC%2BD2sXhsVCgsbfK 10.1586/14737159.8.1.73 18088232
20. SH Tan MT Nevalainen 2008 Signal transducer and activator of transcription 5A/B in prostate and breast cancers Endocr Relat Cancer 15 367 390 1:CAS:528:DC%2BD1cXosVGjsrw%3D 10.1677/ERC-08-0013 18508994 (Pubitemid 351880829)
21. H Li TJ Ahonen K Alanen, et al. 2004 Activation of signal transducer and activator of transcription 5 in human prostate cancer is associated with high histological grade Cancer Res 64 4774 4782 1:CAS:528:DC%2BD2cXls1OmsLc%3D 10.1158/0008-5472.CAN-03-3499 15256446 (Pubitemid 38924520)
22. H Li Y Zhang A Glass, et al. 2005 Activation of signal transducer and activator of transcription-5 in prostate cancer predicts early recurrence Clin Cancer Res 11 5863 5868 1:CAS:528:DC%2BD2MXos1CjtbY%3D 10.1158/1078-0432.CCR-05- 0562 16115927 (Pubitemid 41170314)
23. RP de Groot JA Raaijmakers JW Lammers, et al. 2000 STAT5-dependent cyclin D1 and Bcl-xL expression in Bcr-Abl-transformed cells Mol Cell Biol Res Commun 3 299 305 10.1006/mcbr.2000.0231 10964754
24. JR Nevins 1992 E2F: a link between the Rb tumor suppressor protein and viral oncoproteins Science 258 424 429 1:CAS:528:DyaK3sXht1Wrs78%3D 10.1126/science.1411535 1411535
25. WS Huang JP Wang T Wang, et al. 2007 ShRNA-mediated gene silencing of beta-catenin inhibits growth of human colon cancer cells World J Gastroenterol 13 6581 6587 1:CAS:528:DC%2BD1cXhslSksbo%3D 10.3748/wjg.13.6581 18161931
26. BE Shan MX Wang RQ Li 2009 Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway Cancer Investig 27 604 612 1:CAS:528:DC%2BD1MXnvVOmt7Y%3D 10.1080/07357900802337191
27. A Itami Y Shimada G Watanabe, et al. 1999 Prognostic value of p27(Kip1) and CyclinD1 expression in esophageal cancer Oncology 57 311 317 1:CAS:528:DyaK1MXnvVKktLY%3D 10.1159/000012067 10575318
28. Y Umekita Y Ohi Y Sagara, et al. 2002 Overexpression of cyclinD1 predicts for poor prognosis in estrogen receptor-negative breast cancer patients Int J Cancer 98 415 418 1:CAS:528:DC%2BD38XitVWju7k%3D 10.1002/ijc.10151 11920593 (Pubitemid 34188685)
29. DS Arici E Tuncer H Ozer, et al. 2009 Expression of retinoblastoma and cyclin D1 in gastric carcinoma Neoplasma 56 63 67 1:STN:280: DC%2BD1M%2FotFKntQ%3D%3D 10.4149/neo-2009-01-63 19152247
30. ZJ Fu ZY Ma QR Wang, et al. 2008 Overexpression of CyclinD1 and underexpression of p16 correlate with lymph node metastases in laryngeal squamous cell carcinoma in Chinese patients Clin Exp Metastasis 25 887 892 1:CAS:528:DC%2BD1MXht1yqsbs%3D 10.1007/s10585-008-9207-x 18787961